Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2

Status

Completed 9Active not recruiting 4Unknown 1Terminated 1Recruiting 1

Sponsor Class

OTHER 31INDUSTRY 22NIH 6NETWORK 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 3Genitourinary 1

Conditions

Prostatic Neoplasms 1Breast Neoplasms 1Breast Neoplasm Female 1Breast Cancer Recurrent 1

Interventions

Specimen Handling 19Cyclophosphamide 18Magnetic Resonance Spectroscopy 17Vincristine 16Dexamethasone 15Radiotherapy 14Cisplatin 14Radiation 12Etoposide 11Doxorubicin 11Radiotherapy, Intensity-Modulated 10Carboplatin 10durvalumab 9Paclitaxel 9Cytarabine 8Temozolomide 7Rituximab 7Radiotherapy, Conformal 7Prednisone 7Lenalidomide 7Irinotecan 7Gemcitabine 7Fluorouracil 7Docetaxel 7Bortezomib 7Biopsy 7daratumumab 6Platinum 6Leucovorin 6Capecitabine 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Active not recruiting × NETWORK × palbociclib × Clear all
NCT03425838 2026-05-20

Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer

Borstkanker Onderzoek Groep

Phase 3 Active not recruiting
1,050 enrolled
Breast

Breast Neoplasm Female

NCT03609047 2026-05-12

Appalaches

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Active not recruiting
366 enrolled
Breast

Breast Neoplasms

NCT03820830 2026-04-09

POLAR

ETOP IBCSG Partners Foundation

Phase 3 Active not recruiting
405 enrolled
Breast

Breast Cancer Recurrent

NCT02905318 2026-03-09

Palbociclib in Patients With Metastatic Castration-Resistant Prostate Cancer

Canadian Cancer Trials Group

Phase 2 Active not recruiting
19 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡